| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 32,115 | 35,587 | 32,605 | | Cost of Revenue | 10,497 | 12,354 | 10,047 | | | Gross Profit | 21,618 | 23,233 | 22,557 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 13,449 | 12,293 | 11,307 | | Non Recurring |
-
|
-
|
-
| | Others | 15,821 | 625 | 388 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (7,653) | 10,315 | 10,862 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (7,653) | 10,315 | 10,862 | | Interest Expense | 1,963 | 4,624 | 4,745 | | Income Before Tax | (9,616) | 5,691 | 6,118 | | Income Tax Expense | (3,793) | 1,856 | 2,027 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,823) | 3,836 | 4,091 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,823) | 3,836 | 4,091 | | Preferred Stock And Other Adjustments | (211) |
-
|
-
| | | Net Income Applicable To Common Shares | ($6,034) | $3,836 | $4,091 |
|
0.22% Nasdaq 
Income Statement
